Cargando…

Subjective Cognitive Decline and Alzheimer's Disease Spectrum Disorder

Subjective cognitive decline (SCD) represents subjective complaints about cognitive decline in the absence of objective impairment in neuropsychological tests. Recently, growing evidence has suggested that SCD might be the first symptomatic stage of Alzheimer's disease (AD) spectrum disorders....

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Yun Jeong, Lee, Jae-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Dementia Association 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6427955/
https://www.ncbi.nlm.nih.gov/pubmed/30906369
http://dx.doi.org/10.12779/dnd.2017.16.2.40
Descripción
Sumario:Subjective cognitive decline (SCD) represents subjective complaints about cognitive decline in the absence of objective impairment in neuropsychological tests. Recently, growing evidence has suggested that SCD might be the first symptomatic stage of Alzheimer's disease (AD) spectrum disorders. However, SCD is a heterogeneous condition mixed with AD and non-AD related conditions. Hence, refinement of evidence from previous reports and standardization of the concept about SCD are needed to define appropriate target population with AD pathology. In this article, we review previous studies involving subjects with SCD, the new proposed research criteria, and characteristics of SCD in the aspect of preclinical AD. Biomarker status of SCD is also addressed. Future researches on SCD require a longitudinal follow-up with sufficient biomarker studies and proper outcome measures.